Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease

NCT04374058 is registered in ClinicalTrials.gov with Dialisis Madariaga as lead sponsor.

NCT NCT04374058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04374058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease
Lead sponsor
Dialisis Madariaga
Phase
Observational
Overall status
Unknown status
Start date
March 20, 2020
Completion date
March 31, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease